Adcetris 50 mg, 1 vial (Brentuximab vedotin 50 mg) by Takeda.
Indications: Hodgkin lymphoma (CD30+), systemic anaplastic large cell lymphoma and cutaneous T-cell lymphoma in adults, per SmPC.
Administration: Intravenous infusion over 30 minutes, typically every 3 weeks, under oncologist supervision.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Takeda |
| Active ingredient | Brentuximab vedotin 50 mg (CD30-directed antibody–drug conjugate). |
| Strength & pack | 1 single-use vial. |
| Form | Powder for concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |